BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18062773)

  • 1. ODCp, a brain- and testis-specific ornithine decarboxylase paralogue, functions as an antizyme inhibitor, although less efficiently than AzI1.
    Snapir Z; Keren-Paz A; Bercovich Z; Kahana C
    Biochem J; 2008 Mar; 410(3):613-9. PubMed ID: 18062773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase.
    Kanerva K; Mäkitie LT; Pelander A; Heiskala M; Andersson LC
    Biochem J; 2008 Jan; 409(1):187-92. PubMed ID: 17900240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antizyme 3 inhibits polyamine uptake and ornithine decarboxylase (ODC) activity, but does not stimulate ODC degradation.
    Snapir Z; Keren-Paz A; Bercovich Z; Kahana C
    Biochem J; 2009 Apr; 419(1):99-103, 1 p following 103. PubMed ID: 19076071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor.
    Kahana C
    Essays Biochem; 2009 Nov; 46():47-61. PubMed ID: 20095969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse ornithine decarboxylase-like gene encodes an antizyme inhibitor devoid of ornithine and arginine decarboxylating activity.
    López-Contreras AJ; López-Garcia C; Jiménez-Cervantes C; Cremades A; Peñafiel R
    J Biol Chem; 2006 Oct; 281(41):30896-906. PubMed ID: 16916800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear translocation of antizyme and expression of ornithine decarboxylase and antizyme are developmentally regulated.
    Gritli-Linde A; Nilsson J; Bohlooly-Y M; Heby O; Linde A
    Dev Dyn; 2001 Mar; 220(3):259-75. PubMed ID: 11241834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of antizyme inhibitor, an ornithine decarboxylase homologous protein, is ubiquitin-dependent and is inhibited by antizyme.
    Bercovich Z; Kahana C
    J Biol Chem; 2004 Dec; 279(52):54097-102. PubMed ID: 15491992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
    Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
    Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of ornithine decarboxylase by the 26S proteasome.
    Murakami Y; Matsufuji S; Hayashi S; Tanahashi N; Tanaka K
    Biochem Biophys Res Commun; 2000 Jan; 267(1):1-6. PubMed ID: 10623564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions.
    Keren-Paz A; Bercovich Z; Porat Z; Erez O; Brener O; Kahana C
    Oncogene; 2006 Aug; 25(37):5163-72. PubMed ID: 16568078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
    Nilsson J; Grahn B; Heby O
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of all members of the antizyme family by antizyme inhibitor.
    Mangold U; Leberer E
    Biochem J; 2005 Jan; 385(Pt 1):21-8. PubMed ID: 15355308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking of antizyme to ornithine decarboxylase and antizyme inhibitor using experimental mutant and double-mutant cycle data.
    Cohavi O; Tobi D; Schreiber G
    J Mol Biol; 2009 Jul; 390(3):503-15. PubMed ID: 19465028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a novel human ornithine decarboxylase-like protein in the central nervous system and testes.
    Pitkänen LT; Heiskala M; Andersson LC
    Biochem Biophys Res Commun; 2001 Oct; 287(5):1051-7. PubMed ID: 11587527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of ornithine decarboxylase in Saccharomyces cerevisiae is ubiquitin independent.
    Gandre S; Kahana C
    Biochem Biophys Res Commun; 2002 Apr; 293(1):139-44. PubMed ID: 12054575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation.
    Keren-Paz A; Bercovich Z; Kahana C
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical factors governing the difference in antizyme-binding affinities between human ornithine decarboxylase and antizyme inhibitor.
    Liu YC; Liu YL; Su JY; Liu GY; Hung HC
    PLoS One; 2011 Apr; 6(4):e19253. PubMed ID: 21552531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for antizyme inhibitor in cell proliferation.
    Silva TM; Cirenajwis H; Wallace HM; Oredsson S; Persson L
    Amino Acids; 2015 Jul; 47(7):1341-52. PubMed ID: 25813938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal antizyme peptide fully functioning in the binding and inhibition of ornithine decarboxylase and antizyme inhibitor.
    Hsieh JY; Yang JY; Lin CL; Liu GY; Hung HC
    PLoS One; 2011; 6(9):e24366. PubMed ID: 21931692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, assay, and functional analysis of the antizyme inhibitor family.
    Kahana C
    Methods Mol Biol; 2011; 720():269-78. PubMed ID: 21318879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.